• anujshah.onco@gmail.com
  • Epic Hospital, Rajpath Rangoli Rd, off Sarkhej - Gandhinagar Highway, Bodakdev, Ahmedabad

Best HIPEC Treatment in Ahmedabad

Advanced, Targeted Treatment for Peritoneal Surface Cancers

Advanced HIPEC Treatment for Peritoneal Cancer

An advanced and highly specialized cancer treatment designed for patients with cancers that have spread to the lining of the abdominal cavity (peritoneum).

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an advanced and highly specialized cancer treatment designed for patients with cancers that have spread to the lining of the abdominal cavity (peritoneum). This approach combines extensive tumor-removal surgery with direct, heated chemotherapy delivery, targeting cancer cells at their source. HIPEC allows oncologists to treat peritoneal disease more aggressively and precisely, offering selected patients improved disease control, reduced recurrence risk, and better long-term outcomes compared to systemic chemotherapy alone.

WHAT IS HIPEC?

HIPEC is a procedure performed immediately after cytoreductive surgery, during which heated chemotherapy is circulated throughout the abdominal cavity before surgical closure.

Unlike intravenous chemotherapy, HIPEC delivers high concentrations of anticancer drugs directly to the affected surfaces, allowing better penetration into residual microscopic cancer cells while minimizing exposure to the rest of the body.

The heat enhances the effectiveness of chemotherapy by increasing cancer cell sensitivity and improving drug absorption at the cellular level.

HIPEC Treatment

WHEN IS HIPEC RECOMMENDED?

HIPEC is recommended for carefully selected patients whose cancer is primarily confined to the peritoneal surfaces and can be surgically reduced to minimal disease.

01

Peritoneal metastasis from colorectal or gastric cancers

02

Appendiceal tumors, including pseudomyxoma peritonei

03

Advanced or recurrent ovarian cancer in selected cases

04

Peritoneal mesothelioma

05

Limited peritoneal spread

TYPES OF CANCERS TREATED WITH HIPEC

HIPEC is part of a comprehensive, multidisciplinary treatment strategy for specific abdominal cancers.

GI Cancers

Gastrointestinal Cancers

Cancers of the colon, appendix, stomach, and small intestine that spread to the peritoneum may benefit from HIPEC when visible disease can be surgically removed.

Gynecologic Cancer

Gynecologic Cancers

In selected patients with advanced or recurrent ovarian cancer, HIPEC can reduce microscopic residual disease following tumor debulking surgery.

Primary Peritoneal Malignancies

Primary Peritoneal Malignancies

Diseases such as pseudomyxoma peritonei and peritoneal mesothelioma are classic indications for HIPEC, as the cancer primarily involves the peritoneal lining.

PROCEDURE DETAILS AND APPROACHES

HIPEC is performed in a single operative session under general anesthesia and involves two integrated treatment phases.

Cytoreductive Surgery

Cytoreductive Surgery (CRS)

Removal of all visible tumor deposits from the abdominal cavity

May include resection of affected organs or peritoneal surfaces

Objective is to achieve minimal or no visible residual disease

The success of HIPEC largely depends on the completeness of tumor removal during this stage.

Heated Chemotherapy Circulation

Chemotherapy solution heated to 41–43°C

Circulated within the abdomen for 60–90 minutes

Continuous movement ensures uniform drug distribution

Heat enhances chemotherapy effectiveness by damaging cancer cells and increasing drug penetration.

Heated Chemotherapy
Targeted Local Therapy Advantage

Targeted Local Therapy Advantage

High local drug concentration at tumor sites

Limited systemic absorption and toxicity

Improved effectiveness against microscopic residual disease

BENEFITS OF HIPEC

Enhanced destruction of residual cancer cells

Improved penetration of chemotherapy due to heat

Lower systemic toxicity compared to IV chemotherapy

Single-session treatment combined with surgery

Experience, Expertise, & Compassion

You Can Trust

Specialized Oncologic Training

Trained in surgical oncology with focused expertise in advanced cytoreductive surgery and HIPEC procedures.

Experience with Peritoneal Malignancies

Skilled in managing complex peritoneal cancers, including ovarian, gastrointestinal, and mesothelioma-related cases.

Experience, Expertise, & Compassion

You Can Trust Us for HIPEC Treatment

Global Exposure

Familiar with international best practices and innovations in intraperitoneal chemotherapy from training in India and the USA.

Minimally Invasive Expertise

Proficient in combining cytoreductive surgery with HIPEC for optimal tumor removal and minimal impact on patient recovery.

Dr. Anuj believes that the best surgical approach is the one personalized to the patient, not a one size fits all method. Every decision is made with the aim of:

Maximum cancer clearance

Minimum complications

Better long-term quality of life

HIPEC Treatment

FAQs

Frequently Asked Questions

HIPEC aims to eliminate microscopic cancer cells remaining after surgical tumor removal.

No, it is suitable only for selected patients after detailed evaluation.

When performed in experienced centers, HIPEC is safe with manageable risks.

CRS and HIPEC together may take several hours depending on disease extent.

Some patients may require additional systemic therapy based on pathology results.

Dr Anuj Suketu GI Cancer

Book a Consultation

Dr. Anuj offers expert guidance, minimally invasive treatment, and compassionate care throughout the process.

Need Any Help? We’re There For You

HIPEC offers a powerful treatment option for selected patients with peritoneal malignancies.

Scroll to Top